Clinical Trial Update: A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome [Phase 2]

View source ↗

Summary

Phase II study of KCT-0809 in patients with dry eye disease has completed, according to the trial status update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• KCT-0809

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Dry Eye Syndromes | Phase 2 | Status: COMPLETED